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The effect of indomethacin (IND) on the mitogenic responses of human peripheral blood 
lymphocytes was dependent upon the dose of mitogen employed; in contrast, the effect of 
prostaglandins (PCs) was independent of the mitogen dose. When a single concentration of 
mitogen was used to study the effect of IND on blastogenesis, extremely variable results were 
observed, even among a healthy population group. This variability within the group was 
reduced to a minimum when mitogen dose-response studies were performed with and 
without IND and maximal blastogenic responses were compared. Employing such acriterion, 
no age-related differences were noted on addition of IND. Kinetic experiments revealed that 
significant quantities of PGs must be present very early during the culture period to influence 
the lectin-induced mitogenesis. These findings, together with recently published data from 
other laboratories, lead us to conclude that endogenously synthesized PGs may not be able to 
influence the lectin-induced mitogenic process. The effect of IND observed at submitogenic 
doses of lectins may be due to other pharmacological actions such as its effect on cyclic 
AMP-dependent protein kinases. 
INTRODUCTION 
Regulation of immune function by hormones, vasoactive amines, and anti- 
inflammatory drugs is presently in the forefront of immunological research. 
Receptors for histamine, the p-mimetic catecholamines, and the prostaglandins 
(PGs) of the E and A Series (for review, see 1) have been demonstrated on human 
and murine lymphocytes. Moreover, PGs have been shown to be active in the 
inhibition of T-cell functions (2), control of the 19 S antibody response to sheep 
erythrocytes (3), inhibition of cytolytic activity (4), and inhibition of lymphokine 
secretion from sensitized human lymphocytes (5). Thus, PGs are being attributed a 
prominent role as modulators of immune function in a variety of conditions. The 
evidence implicating PGs in immune regulation is based on the ability of a 
prostaglandin synthetase inhibitor, indomethacin (IND), to enhance the mitogenic 
responses of lectin-stimulated peripheral blood lymphocytes (PBL) in vitro and the 
ability of exogenously added PGs to inhibit lectin-induced mitogenic responses. PG 
secretion by peripheral blood mononuclear cells has been attributed to a glass 
adherent cell population (6), and increased production of PGs by these cells has 
been implicated in the depressed cellular immunity manifested in Hodgkin’s disease 
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(7), and aging (8). However, the data on the effect of IND on phytohemagglutinin 
(PHA) and concanavalin A (Con A)-stimulated mitogenesis is conflicting and 
inconsistent. Novogrodsky et al. (9) reported that IND failed to show any 
enhancing effect in Con A- and PHA-stimulated cultures. In all these studies the 
experiments were performed using a single mitogen dose. 
In this paper we demonstrate that the effect of IND (1 &ml) on the mitogenic 
response of PBL is dependent upon the concentration of the mitogen used for 
lymphocyte stimulation. Further, since the concentration of mitogen for maximal 
blastogenic response was found to vary from individual to individual, dose-re- 
sponse curves to several mitogens, with and without IND, or exogenous PG were 
determined on PBL from healthy young and aged volunteer donors. We report here 
the results of these experiments, which suggest that the apparent enhancement of 
lectin-induced lymphocyte mitogenesis by IND may involve pharmacological 
actions other than inhibition of prostaglandin synthetase. 
MATERIALS AND METHODS 
Donors. Blood from young and aged healthy volunteer donors was freshly 
obtained from a peripheral vein. All donors gave informed consent consistent with 
institutional and Department of Health, Education, and Welfare policies. The aging 
population ranged from 65 to 74 years with a mean age of 69.3 years; the young adult 
population ranged from 23 to 48 years with a mean of 32.8 years. 
Isolation of lymphocytes. Peripheral blood mononuclear leukocytes were 
prepared from fresh heparinized blood (20 U/ml) by a modification of the density 
gradient technique of Bijyum (10). The mononuclear cell band was harvested and 
washed three times with CA2+- and MG2+-free Hanks’ balanced salt solution (Grand 
Island Biological Co.) and resuspended in RPM1 1640 medium (Grand Island 
Biological Co.) containing 10% heat-inactivated fetal calf serum (Associated 
Biomedic Systems, Inc., Buffalo, N.Y.), 80 pg gentamicin/ml (Schering Corp., 
Kenilworth, N.J.), and 300 pg of fresh glutamine/ml. 
Drugs. PGE1, PGE2, and IND were obtained from a commercial supplier (Sigma 
Chemical Co., St. Louis, MO.). PGE, and PGE2 were dissolved to a concentration 
of 1 mg/ml, and IND to 10 mg/ml in 95% ethyl alcohol. Further dilutions were made 
in RPM1 1640 medium, aliquoted and stored frozen at -20°C. Ethanol alone, at the 
final concentration obtained after adding the drugs to the cultures (~0.01%) had no 
effect on the mitogenic response in the majority of the subjects. However, an 
occasional individual showed a slight enhancement with the ethanol alone. 
Cell cultures. Cells were cultured in round-bottom microtiter plates (Falcon 
Plastics, Oxnard, Calif.) at a concentration of 5 x lo4 cells in 200 ~1. In some 
experiments 2 x lo5 cells were cultured in 200 ,ul of 20% FCS, where noted. 
Mitogens and drugs were added directly to the wells. The final volume of all the 
cultures was adjusted to 240 ~1 and the cells were incubated for 72 hr at 37°C in an 
atmosphere consisting of 5% CO2 and 95% air. At the end of 72 hr, 2 &i of 
[methyl-3H]thymidine, specific activity 6.7 Ci/mmol (rH]thymidine, New England 
Nuclear, Boston, Mass.) was added to each well and cultured for an additional 18 
hr. The cells were harvested by an automatic cell harvester (Flow Laboratories, 
Rockville, Md.) and incorporation of rH]thymidine was measured by liquid 
scintillation spectroscopy. Dose-response curves to PHA-P (Difco Laboratories, 
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Detroit, Mich.) and Con A (Pharmacia Fine Chemicals, Piscataway, N.J.) were 
determined with and without the addition of the various pharmacologic agents. All 
cultures were performed in triplicate and the results expressed as mean + 1 
standard deviation. 
The percentage change induced by IND was calculated according to the formula 
(C, - C)/C x 100, where C1 is counts per minute in the presence of mitogen and 
IND, and C is counts per minute in the presence of mitogen only. 
RESULTS 
Effect of IND on Dose-Response Curves to Con A and PHA 
Figure 1 shows two representative dose-response curves to Con A with and 
without IND, using 5 x lo4 cells per well. In Fig. la, IND evoked a change in 
sensitivity of the lymphocytes to mitogenesis by Con A, resulting in a broadened 
maximum, with comparable responses at both 5 and 10 &ml of Con A. Had a single 
concentration of 5 pg./ml of Con A been solely selected for comparing the effects of 
IND, it would appear that IND caused a marked enhancement of mitogenesis. 
However, when maximal mitogenic responses are compared with and without IND, 
a Con A (pglml) 
701 
FIG. 1. Effect of IND (1 &ml) and PGE, (4.7 x lOma M) on the Con A-induced mitogenic response of 
PBL. Representative dose-response curves from two donors (a and b). 0, Con A; A, Con A + IND; & 
Con A + PGE,. 
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it can be seen that IND had no significant effect on the maximal response. In Fig. lb, 
the Con A dose for optimum response remains unaltered in the presence or absence 
of IND, but the magnitude of the blastogenic response at 10 and 15 pg/ml of the 
mitogen differs significantly on adding IND. These two dose-response curves 
illustrate the great variability of the effect of IND. Further, among the persons 
tested in this study, the optimum Con A dose varied from 5 to 25 pg/ml under similar 
conditions. For this reason, we propose that a comparison of the maximal mitogenic 
response in the presence and absence of IND is a preferable measure of the 
immunoregulatory effect of this agent on lectin-induced mitogenesis. 
Figure 2 shows dose-response curves to PHA-P with and without IND. In Fig. 
2a, IND does not exert an effect on mitogenesis at any lectin dose tested. With PBL 
from another healthy donor there was a shift in the optimum to a higher mitogen 
dose in the presence of IND but no change in the magnitude of the maximal 
mitogenic response (Fig. 2b), thus indicating that the use of a full dose-response 
curve is a more informative parameter of the effect of IND on any lectin-induced 
mitogenesis. 
I 
1 10 20 40 80 12lJ 160 320 
a PHA (rrglml) 
b PHA (og/ml) 
FIG. 2. Effect of IND (1 &ml) on the mitogenic response of PBL induced by PHA. 
dose-response curves from two donors (a and b). 0, PHA; A, PHA + IND. 
Representative 
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Con A (pglmlt 
FIG. 3. Effect of IND (1 &ml) on the dose-response curve of Con A using 2 x lo5 cells per well and 
20% FCS. 0, Con A; A, Con A + IND. 
The optimum mitogen concentration for maximal blastogenic response varies 
considerably with the experimental conditions employed. When experiments were 
performed using 2 x lo5 cells per well and 20% FCS the results shown in Fig. 3 were 
obtained. It can be seen that the mitogenic response does not show a downtrend 
even at 40 pg/ml of Con A; further, when IND is present in the culture the optimum 
shifts to 20 pg/ml of Con A and the mitogenic response begins to decrease at 40 
&ml, again demonstrating that at mitogen concentrations approaching optimal, 
IND fails to cause enhancement in blastogenesis. However, under these 
conditions, if the change induced by IND is expressed as the percentage change at a 
single mitogen concentration (e.g., 5 &ml Con A) the data would appear as shown 
in Fig. 4. We would like to point out that 5 pg/ml Con A under these conditions was a 
suboptimal dose. Further, the data as presented in Fig. 4 reveal that some normal 
individuals show as much as 337% enhancement in the presence of IND. 
Effect of ZND on Lymphocytes from Young and Aged Individuals 
Table 1 summarizes the results of the IND effect on Con A-induced mitogenesis 
at a cell concentration of 50,000 PBL per well. The effect of IND was determined by 
performing dose-response curves to Con A with and without IND and comparing 
the maximal mitogenic responses. In 8 of 11 healthy young persons, IND failed to 
show a singificant change (P value ~0.05) in the maximal blastogenic response; 
with PBL from one individual there was enhancement of the peak response with 
IND, whereas PBL from another donor yielded a lower maximal mitogenic 
response in the presence of IND. Using PBL from 10 healthy aged individuals, 
addition of IND to mitogen-stimulated cultures caused no change in 7, 
enhancement in 2, and suppression in 1, thus indicating no difference in response to 
IND between the two groups. 
Effect of PGEp on the Mitogenic Response 
Among the 16 persons, both young and aged, studied for PG influence, there was 
consistent suppression of transformation responses to all doses of Con A tested at a 
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FIG. 4. Effect of IND (1 &ml) on Con A-stimulated mitogenic responses expressed as a percentage 
change, using 2 x lo5 cells per well and 20% FCS. 
final concentration of 2.35 x lop8 M PGEz. The only exception was a 23-year-old 
female whose PBL showed a slight enhancement of mitogenesis when PGEz was 
added. A typical dose-response to Con A at various concentrations of PGE, 
ranging from 2.35 X IO+ M to 1.8 x lo-’ M is shown in Fig. 5. 
Time-Course Experiments with PGE, 
PGE, was added to the wells at various time intervals after initiation of the 
cultures with Con A. Figure 6 shows that the addition of PGEz at 0 and 2 hr 
suppressed the mitogenic response, but by 4 hr the suppression was partially lost 
and addition of PGE, at 16 hr failed to suppress mitogenesis. 
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TABLE 1 
Effect of Indomethacin on the Mitogenic Response of PBL to Con A 
[3H]Thymidine incorporation (cpm) in response to mitogens” 













































67,371 + 16,268 56,885 r 1,458 
33,972 ? 11,370 27,261 k 13,264 
77,734 2 10,430 31,428 + 5,497 
35,358 + 4,186 27,983 + 3,071 
67,721 k 5,988 67,476 ? 12,055 
126,827 2 17,962 129,646 k 21,034 
84,264 2 5,238 94,409 k 9,424 
49,815 k 9,098 39,812 + 5,414 
75,206 2 6,222 107,949 r 11,391 
52,830 + 6,647 50,845 k 7,452 
129,637 k 4,012 118,716 2 5,091 
106,628 e 12,510 47,442 + 7,970 
49,625 + 18,467 112,559 zk 11,124 
26,761 -e 4,122 27,779 2 2,793 
71,033 t 1,782 73,242 2 4,658 
32,036 + 4,770 35,273 t 3,734 
17,538 k 2,181 26,523 2 5,378 
14,282 k 3,280 33,048 + 3,667 
18,197 5 2,865 25,372 2 4,894 
8,356 + 908 9,570 * 744 












0 5 x lo* donor lymphocytes were cultured for 72 hr in the presence of various Con A doses with 
and without added IND (1 &ml) and labeled with 2 &i [3H]thymidine as described under Ma- 
terials and Methods. The maximal responses -+ 1 SD are presented for each dose-response curve. 
* 0, No change: +, enhancement; -, suppression; significant at P value cO.05. 
DISCUSSION 
The hypothesis that PGs may have a profound influence on the immune response 
and that abnormalities of PG metabolism may explain some immune-deficient states 
is an exciting proposition. The influence of PGs on the immune response is based, in 
part, on the effects of IND on lectin-induced in vitro mitogenic responses and partly 
on the effects of the addition of exogenous PGs to cultures of PBL. However, the 
data on the effect of IND on the in virro lectin-induced mitogenic response of PBL 
are conflicting and inconsistent. It was originally reported that IND had an 
enhancing effect, at all concentrations of the mitogen tested (6). Later reports 
indicated that the effect of IND is dependent upon the mitogen dose (11). Other 
investigators observed that IND failed to cause any change in the mitogenic 
response induced by Con A and PHA (9). Our results demonstrate that the effect of 
IND depends upon the dose of the mitogen employed. Further, at optimal 
concentrations of the mitogen, IND fails to cause any enhancement of 
blastogenesis, which may explain why some investigators were unable to observe 
enhancement of mitogenesis by IND in their studies. 
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FIG. 5. Effect of PGEI on the mitogenic response of Con A-stimulated PBL. 0, Con A; A, Con 
A + PGE, (2.35 x lo-*M); A, Con A + PGE, (4.7 x 10-8M); 0, Con A + PGE, (9.4 x lO-EM); 0, 
Con A + PGE, (1.8 x 10-‘&f). 
This observation of dose dependency of the IND effect raises an important issue. 
Our own experiments and other studies (12) indicate that no single mitogen dose is 
optimal for all individuals. Therefore, the employment of a single dose of mitogen 
could lead to optimal responses by PBL from some donors and suboptimal 
responses by others. This variation in dose response may become more critical 
when comparing a normal population with a disease population. In Fig. 4 we report 
the data using a single concentration of Con A (5 &ml) expressing the results 
as a percentage change. We wish to point out the great variability of the effect of 
IND as presented in that figure; however, these individual differences disappear 
when dose-response studies are performed and the optimal mitogenic responses 
are compared with and without IND. (Table 1). It should also be noted that in Fig. 4 
three healthy individuals showed as much enhancement at a concentration of 5 
Icg/ml of Con A as had been previously reported for Hodgkin’s disease patients (7). 
Based on these observations, we conclude that the use of a single mitogen dose for 
comparing the effect of IND on different population groups could lead to quite 
variable results, and may further yield misleading conclusions, especially, when the 
Con A (pglml) 
FIG. 6. Effect of the addition of PGE, (4.7 x 10-8M) at various time intervals after the initiation of the 
culture of PBL with Con A. 0, Con A; Cl, Con A + PGEz (0 hr); H, Con A + PGE, (2 hr); A, Con 
A + PGE, (4 hr); 0, Con A + PGE, (16 hr). 
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sample size is small. However, when dose-response curves are performed with 
and without IND and the maximal mitogenic responses are compared, the variation 
within a healthy control population is minimal. Therefore, we propose that it is 
essential to perform such dose-response experiments with and without IND to 
draw meaningful conclusions between any two population groups. 
In the above discussion we endeavored to explain the possible reasons for 
discrepancies in the literature pertaining to the effect of IND on lectin-induced 
lymphocyte transformation. Now, we shall address ourselves to the more 
fundamental issue of whether the effect of IND is due to its actions on the inhibition 
of prostaglandin synthesis or due to some other pharmacological activity of IND. 
Second, is the effect of PG physiological or only pharmacological? 
Figure 1 reveals that the effect of IND was dependent upon the dose of the 
mitogen; in contrast, the effect of PGEz was independent of mitogen concentration. 
That is, the biological effect of IND was not diametrically opposite to that of PG. If 
IND were exerting its effect by inhibiting PG synthesis one might expect 
enhancement of the transformation response even at the optimum concentration of 
the mitogen. 
Next let us consider the effect of PG itself. If endogenously synthesized PGs 
suppress the lectin-induced mitogenic process as predicted by the model, it should 
follow that the addition of IND might likewise enhance the mitogenic process at any 
concentration of the mitogen. The inability of IND to show enhancement of 
blastogenesis at optimal doses of the mitogen is explained on the basis of a lack of 
sensitivity to PG as the mitogen concentration is increased (11). However, in Fig. 1 
it can be seen that exogenous PG was still capable of suppressing the mitogenic 
response at the optimal dose of Con A. This observation does not support the 
concept of a loss of sensitivity to PG at higher mitogen concentration. 
Figure 5 shows that there was consistent suppression of transformation 
responses at the optimal dose of Con A with concentrations of PGE, ranging from 
2.35 x lo-* to 1.8 x lo-‘M. It should be noted that raising the concentration of PG 
eightfold did not cause more suppression than at 2.35 x lo-* M which is considered a 
physiological concentration. This experiment indicates that if endogenously 
produced PGs were already exerting a significant suppression in the culture, then 
addition of a small amount of exogenous PG would not be expected to cause a 
noticeable change. The fact that the mitogenic response is so exquisitely sensitive 
to exogenous PGs leads one to consider the role of endogenously produced PG 
more critically. 
In the studies implicating the role of endogenous PGs in pathological states, the 
levels of PG produced by in vitro cultures of PBL were measured at the end of a 
48-hr culture period. Kinetic studies on PG synthesis by PBL, in vitro, have shown 
that it takes approximately 16 hr or more following a mitogenic stimulus to observe 
a noticeable change in the production of PG in the culture as compared to 
nonstimulated cells (11, 13). However, within minutes after the addition of a 
mitogen many events are triggered in the lymphocyte and these early events commit 
the cells to blastogenesis (14). Our kinetic experiments show that the same 
concentration of exogenous PG which was capable of causing suppression at 0 hr 
failed to show suppression of mitogenesis when added 16 hr after Con A 
stimulation. This experiment clearly demonstrates that significant concentrations 
of PG must be present very early in the course of mitogenesis to be able to influence 
the process. Therefore, the concentrations of PGs measured at the end of a 48-hr 
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culture period may not bear much relevance to the events taking place early in 
mitogenesis. 
Recent evidence indicates that picomole quantities of PGEz are produced within 
1 hr of stimulation with PHA. However, inhibition of this early PGEz production by 
IND failed to alter the mitogenic responses of lymphocytes (15), thus supporting 
our view that the small amount of PGE, produced during the first few hours of 
mitogenesis is incapable of influencing the lectin-induced response. 
If our proposition that endogenously produced PGs are incapable of influencing 
the mitogenic process is correct, it follows that the effect of IND observed at 
submitogenic doses cannot be explained on the basis of PG synthetase inhibition. Is 
it then possible to explain the effect of IND on some other pharmacological basis? 
Recently, IND has been shown to be capable of inhibiting cyclic AMP-dependent 
protein kinases in submicromolar concentrations (16). The authors caution, “In 
addition to inhibiting prostaglandin synthetase, indomethacin exerts effects on a 
variety of enzyme systems at micromolar concentrations or greater, properties 
which should be kept in mind when using this drug to evaluate the role of 
prostaglandins in biological events.” This caveat seems very appropriate to the 
interpretation of IND effects on in vitro immunological parameters. 
The role of cyclic nucleotides in the regulation of lymphocyte proliferation is 
widely recognized (14); therefore, an agent which can influence cyclic AMP- 
dependent protein kinases can very well be capable of affecting the mitogenic 
process induced by lectins. Further, such an action might be susceptible to the dose 
of the mitogen used. Thus, higher concentrations of mitogen might be capable of 
obviating the activity of IND on cyclic AMP-dependent protein kinases. Present 
evidence is insufficient to support a role for cyclic AMP-dependent protein kinases 
in the mitogenic process. However, in view of the potent action of IND on these 
proteins, further studies are clearly indicated before we can attribute the effect of 
IND on mitogenic responses solely to the inhibition of prostaglandin synthesis. 
In conclusion, our observations concur with other studies (6, 7) that PGs 
suppress the mitogenic responses of PBL when added to an in vitro culture; 
however, the use of IND to demonstrate the exclusive effect of endogenously 
produced PGs has certain pitfalls. There is no convincing evidence at the present 
time that endogenously produced PGs can influence the mitogenic process in the in 
vitro culture system. It is our contention that the effects seen on the addition of PGs 
to in vitro cultures may represent a pharmacological effect and may not have much 
physiological significance. The inconsistent results of the effect of IND on the 
mitogenic response reported in the literature may be due to the arbitrary use of 
several different single concentrations of IND in these experiments. Performing 
dose-response curves to mitogen with and without IND and comparing the 
maximal mitogenic responses yields a more consistent result in a given population 
group, and appears essential when comparing different population groups such as 
healthy and diseased populations. Furthermore, additional studies on the 
specificity of the effect of IND are clearly needed before meaningful conclusions 
can be drawn with regard to the effects of PGs in human physiology and pathology. 
Note added in proof: Recently Klimpel et al. (17) reported that Con A and PHA stimulation of 
lymphocytes resulted in activation of soluble cyclic AMP-dependent protein kinase. The non-mitogenic 
agglutinins wheat germ agglutinin and Agarkus bisporus lectin failed to cause such activation. They 
conclude that the activation of cyclic AMP-dependent protein kinase may be one of the early events 
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linked to and regulating lymphocyte mitogenesis. This observation supports our contention that drugs 
capable of affecting the activity of the cyclic AMP-dependent protein kinase (e.g., IND) can modulate 
the lectin-induced mitogenic processes and such modulation is likely to be dependent upon the con- 
centration of the mitogen. 
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